SITC Cancer Immunotherapy CONNECT

2019 SITC Logo Crop

SITC 2019 Deadlines Are Fast Approaching! 
Don't miss SITC's 34th Annual Meeting & Pre-Conference Programs! The early registration deadline is October 9 and housing reservation deadline is October 14.  


SITC's Comprehensive Cancer Immunotherapy Training Program

Attend the SITC Cancer Immunotherapy Winter School on Jan. 13-17, 2020, in Houston, Texas.

Register to Attend Today

SITC Career Connections
Connecting talent seekers with job seekers at all career levels throughout the cancer immunotherapy field.


JITC Increases Impact Factor to 8.676
The Journal for ImmunoTherapy of Cancer (JITC), SITC’s open access, peer-reviewed online journal, has increased its impact factor to 8.676.

New Online Patient Course Available: Understanding Cancer Immunotherapy 
Access SITC’s dedicated resource for patients and caregivers to learn about cancer immunotherapy

Now Available: SITC Cancer Immunotherapy Guidelines – Squamous cell carcinoma of the head and neck (HNSCC)
Learn up-to-date consensus recommendations for immunotherapy of head and neck cancers in this recently published SITC Cancer Immunotherapy Guidelines manuscript.

Stay Current with FDA-Approved Immunotherapy Treatments
Attend an upcoming SITC Advances in Cancer Immunotherapy™ Program

chicago, Ill. on Sept. 28

boston, mass. ON oct. 10

buffalo, N.Y. ON oct. 26

Philadelphia, Pa. ON Nov. 12

View More  Locations


NOW AVAILABLE: SITC's Guide to Managing Immunotherapy Toxicity

A new handbook from SITC for clinicians providing thorough coverage of the toxicity and management of adverse events for immune checkpoint inhibitors.

Purchase Today

2019 Lung Cancer and Immunotherapy Course 
A free, interactive course, part of the Advances in Cancer Immunotherapy™ online education series.

Register Now


Why I'm a SITC Member

Join Patrick Hwu, MD, and the thousands of other cancer immunotherapy professionals who proudly call themselves SITC members.

Become a SITC Member


Inspire the Next Generation of Cancer Immunotherapy Leaders

Advance the science of cancer immunotherapy and help young investigators tackle hurdles facing the field with a gift to the SITC Forward Fund.

Donate Today


Explore resources and educational opportunities for cancer patients and those who advocate for them.







Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.







Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.






Latest Discussions

  • 2019 Annual Cancer Treatment-Related Adverse Events Symposium Friday-Saturday, October 25-26, 2019 Memorial Sloan Kettering Cancer Center  Register online:   Systemic anticancer therapies (cytotoxic ...

  • Posted in: Women in SITC

    I was there and came back with so many great take home messages! 1. Always have an elevator speech ready. I have definitely screwed up some elevator encounters because I didn't have anything to say. I once even rode an uber with an important guy at ASCO ...

  • Posted in: Women in SITC

    Hi Ann Great tips! I hope to be able to attend future meetings! Sent from my iPhone, please excuse any typos and brevity. The information contained in this electronic e-mail transmission and any attachments are intended only for the use of the individual ...

Follow the SITC Twitter Feed.


Connect with colleagues at these Upcoming Events.


Ignite the SITC Sparkathon

Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.


Learn More


The Journal & The Blog

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More


Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.


Learn More